Neoadjuvant Carboplatin and Docetaxel in Triple Negative Breast Cancer
Clinical trial NCT02547987 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT02547987
- Sponsor
- Mothaffar Rimawi
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-11-01
- Primary completion
- 2019-06-25
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.